Sexual Dimorphism of the Aging Kidney: Role of Nitric Oxide Deficiency
Open Access
- 1 June 2008
- journal article
- research article
- Published by American Physiological Society in Physiology
- Vol. 23 (3) , 142-150
- https://doi.org/10.1152/physiol.00001.2008
Abstract
GFR falls with aging in humans and rats due to renal vasoconstriction and structural damage. The rate of deterioration is influenced by race/genetic background, environment, and sex, with females protected. Part of the female advantage relates to protective effects of estrogens. There is little information on impact of aging on the distribution/cardiovascular actions of the estrogen receptor subtypes. In rats, androgens may contribute to injury, but in men, high testosterone levels predict cardiovascular health. In women, the association is controversial. Nitric oxide deficiency contributes to the hypertension and renal dysfunction of aging, which may be delayed in the female.Keywords
This publication has 100 references indexed in Scilit:
- Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: A possible involvement of androgen receptorBiochemical and Biophysical Research Communications, 2007
- Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up studyKidney International, 2007
- Flow‐mediated dilatation in overweight and obese women with polycystic ovary syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 2006
- Arginine, arginine analogs and nitric oxide production in chronic kidney diseaseNature Clinical Practice Nephrology, 2006
- Compensatory kidney growth in estrogen receptor-α null miceAmerican Journal of Physiology-Renal Physiology, 2006
- Estradiol reverses renal injury in Alb/TGF-β1 transgenic miceKidney International, 2004
- 17β-Estradiol increases inducible nitric oxide synthase expression in macrophagesBiochemical and Biophysical Research Communications, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with agingLife Sciences, 1994